216 related articles for article (PubMed ID: 20876211)
41. Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis.
Albig AR; Roy TG; Becenti DJ; Schiemann WP
Angiogenesis; 2007; 10(3):197-216. PubMed ID: 17632767
[TBL] [Abstract][Full Text] [Related]
42. The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration.
Belloni D; Scabini S; Foglieni C; Veschini L; Giazzon A; Colombo B; Fulgenzi A; Helle KB; Ferrero ME; Corti A; Ferrero E
FASEB J; 2007 Oct; 21(12):3052-62. PubMed ID: 17566084
[TBL] [Abstract][Full Text] [Related]
43. A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
Laderach DJ; Gentilini LD; Giribaldi L; Delgado VC; Nugnes L; Croci DO; Al Nakouzi N; Sacca P; Casas G; Mazza O; Shipp MA; Vazquez E; Chauchereau A; Kutok JL; Rodig SJ; Elola MT; Compagno D; Rabinovich GA
Cancer Res; 2013 Jan; 73(1):86-96. PubMed ID: 23108139
[TBL] [Abstract][Full Text] [Related]
44. Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo.
Cartland SP; Genner SW; Zahoor A; Kavurma MM
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27918462
[TBL] [Abstract][Full Text] [Related]
45. Comparative study of the glycan specificities of cell-bound human tandem-repeat-type galectin-4, -8 and -9.
Vokhmyanina OA; Rapoport EM; André S; Severov VV; Ryzhov I; Pazynina GV; Korchagina E; Gabius HJ; Bovin NV
Glycobiology; 2012 Sep; 22(9):1207-17. PubMed ID: 22547138
[TBL] [Abstract][Full Text] [Related]
46. Plump endothelial cells integrated into pre-existing venules contribute to the formation of 'mother' and 'daughter' vessels in pyogenic granuloma: possible role of galectin-1, -3 and -8.
Arciniegas E; Carrillo LM; Rojas H; Pineda J; Ramírez R; Reyes O; Chopite M; Rocheta A
Scars Burn Heal; 2021; 7():2059513120986687. PubMed ID: 33796337
[TBL] [Abstract][Full Text] [Related]
47. Tumor cells secrete galectin-1 to enhance endothelial cell activity.
Thijssen VL; Barkan B; Shoji H; Aries IM; Mathieu V; Deltour L; Hackeng TM; Kiss R; Kloog Y; Poirier F; Griffioen AW
Cancer Res; 2010 Aug; 70(15):6216-24. PubMed ID: 20647324
[TBL] [Abstract][Full Text] [Related]
48. Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface.
Carlsson S; Oberg CT; Carlsson MC; Sundin A; Nilsson UJ; Smith D; Cummings RD; Almkvist J; Karlsson A; Leffler H
Glycobiology; 2007 Jun; 17(6):663-76. PubMed ID: 17339281
[TBL] [Abstract][Full Text] [Related]
49. Clec14a is specifically expressed in endothelial cells and mediates cell to cell adhesion.
Rho SS; Choi HJ; Min JK; Lee HW; Park H; Park H; Kim YM; Kwon YG
Biochem Biophys Res Commun; 2011 Jan; 404(1):103-8. PubMed ID: 21095181
[TBL] [Abstract][Full Text] [Related]
50. Novel role for ALCAM in lymphatic network formation and function.
Iolyeva M; Karaman S; Willrodt AH; Weingartner S; Vigl B; Halin C
FASEB J; 2013 Mar; 27(3):978-90. PubMed ID: 23169771
[TBL] [Abstract][Full Text] [Related]
51. Calcitonin stimulates multiple stages of angiogenesis by directly acting on endothelial cells.
Chigurupati S; Kulkarni T; Thomas S; Shah G
Cancer Res; 2005 Sep; 65(18):8519-29. PubMed ID: 16166333
[TBL] [Abstract][Full Text] [Related]
52. A novel role for inducible Fut2 in angiogenesis.
Tsou PS; Ruth JH; Campbell PL; Isozaki T; Lee S; Marotte H; Domino SE; Koch AE; Amin MA
Angiogenesis; 2013 Jan; 16(1):195-205. PubMed ID: 23065099
[TBL] [Abstract][Full Text] [Related]
53. Involvement of endothelial PECAM-1/CD31 in angiogenesis.
DeLisser HM; Christofidou-Solomidou M; Strieter RM; Burdick MD; Robinson CS; Wexler RS; Kerr JS; Garlanda C; Merwin JR; Madri JA; Albelda SM
Am J Pathol; 1997 Sep; 151(3):671-7. PubMed ID: 9284815
[TBL] [Abstract][Full Text] [Related]
54. Regulatory roles of galectins in the immune response.
Liu FT
Int Arch Allergy Immunol; 2005 Apr; 136(4):385-400. PubMed ID: 15775687
[TBL] [Abstract][Full Text] [Related]
55. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy.
Thijssen VL; Postel R; Brandwijk RJ; Dings RP; Nesmelova I; Satijn S; Verhofstad N; Nakabeppu Y; Baum LG; Bakkers J; Mayo KH; Poirier F; Griffioen AW
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15975-80. PubMed ID: 17043243
[TBL] [Abstract][Full Text] [Related]
56. Anti-angiogenesis effect of trichosanthin and the underlying mechanism.
He D; Jin J; Zheng Y; Bruce IC; Tam S; Ma X
Biochem Biophys Res Commun; 2013 Jan; 430(2):735-40. PubMed ID: 23206700
[TBL] [Abstract][Full Text] [Related]
57. The role of galectins in mediating the adhesion of circulating cells to vascular endothelium.
Souchak J; Mohammed NBB; Lau LS; Dimitroff CJ
Front Immunol; 2024; 15():1395714. PubMed ID: 38840921
[TBL] [Abstract][Full Text] [Related]
58. NEU1 sialidase regulates the sialylation state of CD31 and disrupts CD31-driven capillary-like tube formation in human lung microvascular endothelia.
Lee C; Liu A; Miranda-Ribera A; Hyun SW; Lillehoj EP; Cross AS; Passaniti A; Grimm PR; Kim BY; Welling PA; Madri JA; DeLisser HM; Goldblum SE
J Biol Chem; 2014 Mar; 289(13):9121-35. PubMed ID: 24550400
[TBL] [Abstract][Full Text] [Related]
59. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.
Purhonen S; Palm J; Rossi D; Kaskenpää N; Rajantie I; Ylä-Herttuala S; Alitalo K; Weissman IL; Salven P
Proc Natl Acad Sci U S A; 2008 May; 105(18):6620-5. PubMed ID: 18443294
[TBL] [Abstract][Full Text] [Related]
60. Type IV collagen alpha6 chain-derived noncollagenous domain 1 (alpha6(IV)NC1) inhibits angiogenesis and tumor growth.
Mundel TM; Yliniemi AM; Maeshima Y; Sugimoto H; Kieran M; Kalluri R
Int J Cancer; 2008 Apr; 122(8):1738-44. PubMed ID: 18074349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
